BelHealth Investment Partners, LLC, a New York-based healthcare private equity firm, announced today that it has finalized its acquisition of Beach House Center for Recovery, a leading Substance Use Disorder treatment provider with facilities in Florida. Terms of the transaction were not disclosed.
Founded in 2014 and headquartered in Juno Beach, Florida, Beach House provides treatment to men and women aged 18+ with a primary diagnosis of SUD. Beach House, on its state-of-the-art five-acre campus, offers clients the full continuum of care (inpatient detox through outpatient) and utilizes an abstinence-focused treatment model, while also promoting medication-assisted treatment. Unlike many in the industry, the Company has made significant investments in corporate infrastructure that have translated into excellent clinical care and best-in-class marketing practices. Beach House was founded by serial entrepreneur, Glenn Cohen, who will continue to lead the platform as Chief Executive Officer.
Over the last 24 months, BelHealth has formulated a thesis for an investment in the SUD industry. Now that we have found our partner, our plan is to scale the existing platform via capacity expansion and other organic growth opportunities on the existing campus in Juno Beach. In addition, we plan to open de novo facilities focused on MAT treatment offerings while also scanning the country for strategic add-ons in key geographies. To maximize success and superior outcomes for clients, the Company will continue to develop innovative models that are tailored to combat addiction and promote on-going outpatient treatment.
Glenn Cohen, Founder and Chief Executive Officer of Beach House, said “I am proud of what our team at Beach House has been able to accomplish over the last few years and we are thrilled to be partnering with the BelHealth team to help continue our ascent. We look forward to leveraging their experience and network as we aggressively grow our established platform throughout different geographies and care settings”.
Harold S. Blue, Managing Partner of BelHealth added, “Our team has searched exhaustively throughout the SUD industry over the last two years to find the best managed company. In Beach House and Glenn Cohen, we have found it. As the amount of people in need of treatment continues to grow, providers require substantial resources and unmatched sophistication in order to provide world-class care while also meeting the demands of commercial payors. Beach House has a proven clinical track-record, a tremendous management team and an established corporate infrastructure, which makes the Company well-positioned for robust growth”.
About Beach House Center for Recovery
Founded in 2014, Beach House Center for Recovery is a nationally recognized drug and alcohol treatment provider, offering a full continuum of medically and clinically integrated care to people with substance use and co-occurring disorders. The state-of-the-art treatment facility is located on a beautiful, self-contained, five-acre recovery campus in the coastal town of Juno Beach. The Beach House staff assist clients at all levels of care, including medically managed detox, residential inpatient, outpatient and continuing care phases of recovery. Clients receive highly individualized treatment options within a supportive, family-like setting that emphasizes the healing power of love and connection. With client outcomes that outperform the industry average, Beach House is known as a trusted provider of evidence-based, outcome-informed addiction treatment and a center for clinical excellence.
About BelHealth Investment Partners
BelHealth Investment Partners, based in New York, is a healthcare private equity firm focused on lower middle market companies. BelHealth has a unique combination of investing, executive management and entrepreneurial experience. BelHealth acquires majority positions in entrepreneur-owned companies that it believes would benefit from its extensive operating and private equity investment expertise. The firm invests across three core healthcare segments: Services, Products and Distribution. BelHealth is investing from its current $350 million fund.
